Linda Hammerich

Charité - Universitätsmedizin Berlin — Germany

Immunology and Microbiology · Life Sciences

26h-index4.0kcitations111works14.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(30), Immunotherapy and Immune Responses(27), Cancer Immunotherapy and Biomarkers(22), Liver Disease Diagnosis and Treatment(17), CAR-T cell therapy research(15)

Publications110 total

Quantification of overall tumor burden using longitudinal magnetic resonance imaging improves response assessment in orthotopic murine hepatocellular carcinoma models
Scientific Reports·2026Open Access
A novel application tunnel in combination with medical training reduces stress induced by frequent intraperitoneal injections and blood sampling in mice
2026Open Access
Immunologic effects of locoregional therapies for unresectable hepatocellular carcinoma
JHEP Reports·2025Open Access
Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E2 sensitivity in mice with diet-induced MASH
Cell Communication and Signaling·2025· 2 citedOpen Access
Pro-inflammatory secretome from intestinal epithelium recruits regulatory T cells for barrier defence
2025· 1 citedOpen Access
THU-153 Immunometabolism of mononuclear cells from blood and ascites in patients with decompensated cirrhosis: compartment-specific features of metabolic dysfunction
Journal of Hepatology·2025
What must not be named
EMBO Reports·2025· 2 citedOpen Access
Association of the Genetic Variant VEGFA rs3025039 with Incidence and Prognosis of Cholangiocarcinoma
Zeitschrift für Gastroenterologie·2025
Slamming hepatocellular carcinoma: targeting immunosuppressive macrophages via SLAMF7 reprograms the tumor microenvironment
Translational Cancer Research·2024· 1 citedOpen Access
Letter to the Editor: Clonally expanded CD8+ T cells in MASH—Invited guests overstaying their welcome
Hepatology·2024· 1 cited
A comprehensive 26‐color immunophenotyping panel to study the role of the gut‐liver axis in chronic liver diseases
Cytometry Part B Clinical Cytometry·2024· 4 citedOpen Access
Ferroptosis in health and disease
Redox Biology·2024· 240 citedOpen Access
CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization
Frontiers in Immunology·2024· 13 citedOpen Access
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Seminars in Liver Disease·2024· 10 citedOpen Access
Fluorochrome‐dependent specific changes in spectral profiles using different compensation beads or primary cells in full spectrum cytometry
Cytometry Part A·2024· 7 citedOpen Access
Author response for "Fluorochrome‐dependent specific changes in spectral profiles using different compensation beads or primary cells in full spectrum cytometry"
2024
Author response for "Fluorochrome‐dependent specific changes in spectral profiles using different compensation beads or primary cells in full spectrum cytometry"
2024
Revolutionising Immune Monitoring with Flow Cytometry
2024Open Access
The suppressive tumor microenvironment of AFP-positive hepatocellular carcinoma and its therapeutic implications
Translational Gastroenterology and Hepatology·2024· 3 citedOpen Access
Comparing hypothermic oxygenated and normothermic liver machine perfusion: Translation matters
Journal of Hepatology·2023· 7 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Frank Tacke(30), Tom Luedde(12), Christoph Roderburg(10), Joshua Brody(8), Isabella Lurje(8), Felix Heymann(7), Christian Trautwein(7), Raphael Mohr(6), Nikolaus Gaßler(5), Alix Bruneau(5), Sven H. Loosen(5), Henning Jann(5), Ranjan Upadhyay(4), Brian D. Brown(4), Miriam Mérad(4), Wiebke Werner(4), Burcin Özdirik(4), Joeri Lambrecht(4), Lukas Geisler(4), Judit Svensson‐Arvelund(3)